Pharmaceutical
| Sun 19 Apr 2026
Munich, April 20 -- Chiesi Farmaceutici has submitted a patent application for Heteroaryl Derivatives as Ddrs Inhibitors. This invention was developed by Carzaniga Laura, Rancati Fabio, Spencer Jonathan Andrew, Whittaker Benjamin Paul, Hamasova Zuzana, Rizzi Andrea, Mazzucato Roberta, Levanto Stefano, Chapman Robert Stuart Lauri..